EMTRICITABIN TENOF. Mepha 200/245 mg 30 pce

7680661810021 CH-66181 J05AR03 08.03.0.

Reimbursement limitations:

EMT.TEN.M_01

Infection par le VIH-1 (code d‘indication 21222.01)
Prise en charge du traitement d’une infection par …

EMTRICITABIN TENOF. Mepha 200/245 mg 30 pce
EMTRICITABIN TENOF. Mepha 200/245 mg 30 pce
EMTRICITABIN TENOF. Mepha 200/245 mg 30 pce
1 / 3
google

Details

Product number
6618101
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili phosphas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hypromellosum, natrii stearylis fumaras corresp. natrium 3.55 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 132, pro compresso obducto.

Articles (1)

Emtricitabin-Tenofovir-Mepha, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/04/2025
Patient information leaflet
Français
11/04/2025
Patient information leaflet
Italien
11/04/2025
Professional SmPC
Allemand
11/04/2025
Professional SmPC
Français
11/04/2025
Professional SmPC
Italien
11/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
245.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.55 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 72.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66181
Drug name
Emtricitabin-Tenofovir-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
J05AR03
Authorization status
Z
Dispensation category
A
First authorization
31/03/2017
Authorization expiration date
31/12/9999
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion, HIV-Prä-Expositionsprophylaxe

Packaging details

Description (FR)
EMTRICITABIN TENOF. Mepha 200/245 mg 30 pce
Description (DE)
EMTRICITABIN TENOF. Mepha 200/245 mg 30 Stk
Market launch
31/03/2017
Narcotic (BTM)
No

Original drug

Truvada, Filmtabletten
CHF 544.30
View original

Other packaging sizes

EMTRICITABIN TENOF. Mepha 200/245 mg bte 30 pce
30 TABL
View